CPSE:NOVO BPharmaceuticals
Novo Nordisk (CPSE:NOVO B): Revisiting Valuation After Recent Share Price Reset
Novo Nordisk (CPSE:NOVO B) has been quietly grinding higher, with the stock up around 7% over the past month, even after a weaker stretch in the past 3 months and year.
See our latest analysis for Novo Nordisk.
That recent 6.7% one month share price return looks more like a short term reset than a full trend change, given the 1 year total shareholder return of minus 45.1% and 5 year total shareholder return still up 67.2%. This suggests long term believers have been rewarded even as momentum...